Clinical Outcomes of Endoscopic Treatment for Asymptomatic and Symptomatic Common Bile Duct Stones: Incidence and Risk Factors for Post-ERCP Pancreatitis
- 1Department of Gastroenterology, Nara Medical University, Nara 634-8522, Japan
- 2Division of Endoscopy, Nara Medical University, Nara 634-8522, Japan
Abstract
Background/Objectives: Endoscopic retrograde cholangiopancreatography (ERCP) is the standard treatment for common bile duct stones (CBDSs). Current clinical guidelines recommend ERCP irrespective of symptom status. However, accumulating evidence suggests that patients with asymptomatic CBDSs are at an increased risk of post-ERCP pancreatitis (PEP). This study aimed to compare the incidence of PEP between patients with symptomatic and asymptomatic CBDSs and to identify independent risk factors for PEP. Methods: A total of 660 patients with a native papilla who underwent ERCP for CBDSs were retrospectively analyzed. Patients were stratified into symptomatic (n = 468) and asymptomatic (n = 192) groups. The incidence of PEP and its associated risk factors were compared between groups. Results: The incidence of PEP was significantly higher in the asymptomatic than symptomatic group (9.4% vs. 4.5%; p = 0.03). This difference was driven primarily by an increased incidence of mild PEP (6.2% vs. 2.4%; p = 0.02), whereas the rates of moderate and severe PEP were comparable. Pancreatic guidewire-assisted biliary cannulation was more frequent in the asymptomatic group (17.7% vs. 10.3%; p = 0.01) and emerged as an independent predictor of PEP. The asymptomatic group also achieved a significantly higher complete stone removal rate than the symptomatic group (99.0% vs. 95.3%; p = 0.02). Conclusions: ERCP for asymptomatic CBDSs was associated with a higher risk of PEP, primarily mild cases, but yielded favorable stone-related treatment outcomes. Therefore, ERCP is an acceptable treatment for asymptomatic CBDSs when the potential benefits and risks are thoroughly discussed with the patient beforehand.
Related
- Tuberculosis incidence among household contacts of individuals with symptomatic and asymptomatic tuberculosis: A historical cohort study in the Western Cape province of South Africa
- Comparable Norovirus Shedding in Symptomatic and Asymptomatic Individuals: A Hospital-Based Study in Bangladesh
- Asymptomatic and symptomatic recurrence of TB among cured pulmonary TB patients
- Endoscopic management of pancreatic duct stones and stricture in chronic pancreatitis using a fully covered self-expandable metal stent.
- Development and internal validation of CTA-based radiomics models for differentiating symptomatic from asymptomatic unruptured spontaneous intracranial vertebrobasilar artery dissection
BibTeX
@article{hanatani2026clinical,
title = {{Clinical Outcomes of Endoscopic Treatment for Asymptomatic and Symptomatic Common Bile Duct Stones: Incidence and Risk Factors for Post-ERCP Pancreatitis}},
author = {Jun-Ichi Hanatani and Koh Kitagawa and Shohei Asada and Ayana Sueki and Kazuki Watanabe and Yuki Motokawa and Yui Osaki and Tomihiro Iwata and Akihiko Shibamoto and Satoshi Iwai and Yuki Tsuji and Yukihisa Fujinaga and Norihisa Nishimura and Kosuke Kaji and Shinya Sato and Tadashi Namisaki and Akira Mitoro and Hitoshi Yoshiji},
journal = {Journal of clinical medicine},
year = {2026},
month = oct,
doi = {10.3390/jcm15197755},
url = {https://europepmc.org/article/PMC/PMC13666200},
note = {CC BY},
}
RIS
TY - JOUR
TI - Clinical Outcomes of Endoscopic Treatment for Asymptomatic and Symptomatic Common Bile Duct Stones: Incidence and Risk Factors for Post-ERCP Pancreatitis
AU - Jun-Ichi Hanatani
AU - Koh Kitagawa
AU - Shohei Asada
AU - Ayana Sueki
AU - Kazuki Watanabe
AU - Yuki Motokawa
AU - Yui Osaki
AU - Tomihiro Iwata
AU - Akihiko Shibamoto
AU - Satoshi Iwai
AU - Yuki Tsuji
AU - Yukihisa Fujinaga
AU - Norihisa Nishimura
AU - Kosuke Kaji
AU - Shinya Sato
AU - Tadashi Namisaki
AU - Akira Mitoro
AU - Hitoshi Yoshiji
PY - 2026
DA - 2026/10/01
JO - Journal of clinical medicine
DO - 10.3390/jcm15197755
UR - https://europepmc.org/article/PMC/PMC13666200
AB - Background/Objectives: Endoscopic retrograde cholangiopancreatography (ERCP) is the standard treatment for common bile duct stones (CBDSs). Current clinical guidelines recommend ERCP irrespective of symptom status. However, accumulating evidence suggests that patients with asymptomatic CBDSs are at an increased risk of post-ERCP pancreatitis (PEP). This study aimed to compare the incidence of PEP between patients with symptomatic and asymptomatic CBDSs and to identify independent risk factors for PEP. Methods: A total of 660 patients with a native papilla who underwent ERCP for CBDSs were retrospectively analyzed. Patients were stratified into symptomatic (n = 468) and asymptomatic (n = 192) groups. The incidence of PEP and its associated risk factors were compared between groups. Results: The incidence of PEP was significantly higher in the asymptomatic than symptomatic group (9.4% vs. 4.5%; p = 0.03). This difference was driven primarily by an increased incidence of mild PEP (6.2% vs. 2.4%; p = 0.02), whereas the rates of moderate and severe PEP were comparable. Pancreatic guidewire-assisted biliary cannulation was more frequent in the asymptomatic group (17.7% vs. 10.3%; p = 0.01) and emerged as an independent predictor of PEP. The asymptomatic group also achieved a significantly higher complete stone removal rate than the symptomatic group (99.0% vs. 95.3%; p = 0.02). Conclusions: ERCP for asymptomatic CBDSs was associated with a higher risk of PEP, primarily mild cases, but yielded favorable stone-related treatment outcomes. Therefore, ERCP is an acceptable treatment for asymptomatic CBDSs when the potential benefits and risks are thoroughly discussed with the patient beforehand.
SN - 2077-0383
ER -